Showing results (271-280 of 346) with videos related to

Sort By:
Pageof 35
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 15, 2019
Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with LymphomaNeeraj Y Saini, Rima M Saliba, Gabriela Rondon, et al.
American Journal of Hematology|October 20, 2017
Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphomaYasmin Abaza, Hagop M Kantarjian, Stefan Faderl, et al.
Blood Cancer Journal|May 3, 2023
Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patientsOren Pasvolsky, Denái R Milton, Mikael Rauf, et al.
Transplantation and Cellular Therapy|September 27, 2024
A Multicenter Analysis of Allogeneic Transplant Outcomes in Adults with Philadelphia-Like B-Cell Acute Lymphoblastic Leukemia in First Complete RemissionZaid Abdel Rahman, Tamer Othman, Rima M Saliba, et al.
British Journal of Haematology|March 30, 2025
Outcomes of patients with multiple myeloma undergoing autologous transplant with suboptimal pretransplant responseOren Pasvolsky, Muhammad Bilal Abid, Denái R Milton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2017
Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic LeukemiaPartow Kebriaei, Claudio Anasetti, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2014
Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donorsAntonio Di Stasi, Denái R Milton, L M Poon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 17, 2012
Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantationStefan O Ciurea, Victor Mulanovich, Rima M Saliba, et al.
Frontiers in Oncology|April 4, 2022
Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial TumorsDavid S Hong, Marcus O Butler, Russell K Pachynski, et al.
Transplantation and Cellular Therapy|January 2, 2025
Outcomes of Standard-Risk Multiple Myeloma Patients Who Undergo Upfront Autologous Hematopoietic Stem Cell TransplantationOren Pasvolsky, Curtis Marcoux, Zhongya Wang, et al.
Pageof 35